Logo
C

Cell and Gene Therapy Catapult

372 employees

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit ct.catapult.org.uk or visit http://www.gov.uk/innovate-uk.

Investor insights

Funding rounds participated in

$1.5M sweet spot round size

Investor type

Nonprofit

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2012

Funding rounds raised

Total raised

$1.5M

from 2 investors over 1 rounds

C

Cell and Gene Therapy Catapult raised $1.5M on July 12, 2023

Investors: Innovate UK and UK Research and Innovation

FAQ